La start-up Signia Therapeutics vient de signer un accord majeur de licence avec l’Université Claude Bernard de Lyon (UCBL) et l’ ...
LYON, FRANCE (November 28, 2017) – Signia Therapeutics is an emerging company, spin-off company of VirPath laboratoy/Universit ...
We are very proud to announce that Signia Therapeutics is laureate of the i-Lab 2017 award from the French Ministry of Higher Ed ...
Do not hesitate to contact us!
Signia therapeutics.com - Copyright 2018. All right reserved.
